Logo

American Heart Association

  2
  0


Final ID:

How do we SELECT incretin analogues and SUSTAIN their impact? Clinical approaches for short and long-term obesity care

  • Jastreboff, Ania  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Lingvay, Ildiko  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Author Disclosures:
    Ania Jastreboff: DO have relevant financial relationships ; Researcher:Eli Lilly:Active (exists now) ; Advisor:Regeneron:Active (exists now) ; Individual Stocks/Stock Options:Intellihealth:Active (exists now) ; Advisor:Scholar Rock:Active (exists now) ; Advisor:Structure Therapeutics:Active (exists now) ; Advisor:Zealand:Active (exists now) ; Advisor:Weight Watchers:Active (exists now) ; Advisor:Pfizer, Terns Pharmaceuticals:Active (exists now) ; Advisor:Novo Nordisk:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Boehringer Ingelheim, Biohaven:Active (exists now) ; Advisor:Amgen, AstraZeneca:Active (exists now) ; Researcher:Rhythm Pharmaceuticals:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Novo Nordisk:Active (exists now) | Ildiko Lingvay: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
More abstracts from these authors:
SGLT2 guidance in the EHR. Implementation challenges in the EHR.

Lingvay Ildiko, Das Sandeep, Ghazi Lama

Panel Discussion

Jastreboff Ania

You have to be authorized to contact abstract author. Please, Login
Not Available